Management of OAB in Female Patients .

NCT06184334 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Solfenacin
DRUG: Mirabegron
DRUG: Tadalafil 5mg

Sponsor

Elsayed Abdelhalim Elsayed